UnitedTrading

CRDF Buy In Point is Here!

Long
NASDAQ:CRDF   Cardiff Oncology, Inc.
CRDF is at a double support currently. Could be a really good buy in point here. Don't be afraid to buy in small portions. 1st target is $15 to see if we get past that natural resistance.
Options could be a possible way to go as well.

Also, don't forget Cardiff is speaking at a virtual presentation on February 17th.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.